Key Drivers
- Strong Liquidity
- Weak Cash Flow
- Premium Valuation
AIAI Summary
ACA is now best viewed as a merger-arbitrage special situation, not a standalone industrial compounder, because CRH's all-cash $150 offer sets the valuation floor and makes closing certainty the main driver while operating upside is largely capped unless the deal breaks.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Liquidity
- •Weak Cash Flow
- •Premium Valuation
ACA looks financially stable with strong liquidity and lower leverage, but only moderate returns, uneven cash conversion, and a valuation that already reflects much of the quality.
Price Behavior
Key Price Behavior Insights:
- •Range-bound trade
- •Support defended
- •Breakout unconfirmed
ACA has spent last month in a tight consolidation, holding support but still needing a decisive close above $145.30-$145.40 to confirm an upside breakout.
Tight-band consolidation, with a top-of-range close on 2026-08-14
Sentiment & News
Key News Insights:
- •Deal scrutiny
- •Earnings miss
- •Integration risks
Arcosa's news flow was dominated by the pending $150/share CRH takeover, ongoing merger-fairness scrutiny, and a Q2 earnings miss that kept attention on both deal value and operating performance. #M&A
The stock is likely to remain driven by takeover developments and litigation headlines, with limited upside until deal approval and closing clarity improve
Similar Companies in Industrials
Other companies in the same sector with AI ratings